Ftse Mib
39.126,40
1,22%
DAX
23.128,55
2,82%
S&P 500
5.937,51
-0,29%
NASDAQ
18.730,61
-0,62%
Bitcoin
90.295,29
-4,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kura Oncology Inc (KURA) Kura Oncology Inc (KURA) Notizie

Kura Oncology Inc

KURA
7,59
-0,12 (-1,56%)
Ultimo aggiornamento: 16:05:31
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202522:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202522:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202522:05EDGAR2Form 8-K - Current report
26/2/202522:03GLOBEKura Oncology Reports Fourth Quarter and Full Year 2024..
25/2/202513:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
19/2/202513:30GLOBEKura Oncology to Report Fourth Quarter and Full Year 2024..
14/2/202523:30EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
14/2/202502:15EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/2/202513:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
05/2/202522:13EDGAR2Form 8-K - Current report
05/2/202522:01GLOBEKura Oncology and Kyowa Kirin Announce Positive Ziftomenib..
29/1/202502:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:37EDGAR2Form 144 - Report of proposed sale of securities
29/1/202502:37EDGAR2Form 144 - Report of proposed sale of securities
29/1/202502:37EDGAR2Form 144 - Report of proposed sale of securities
29/1/202502:37EDGAR2Form 144 - Report of proposed sale of securities
29/1/202502:37EDGAR2Form 144 - Report of proposed sale of securities
29/1/202502:36EDGAR2Form 144 - Report of proposed sale of securities
14/1/202522:36EDGAR2Form 8-K - Current report
07/1/202523:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/1/202523:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/1/202522:35EDGAR2Form 8-K - Current report
06/1/202522:30GLOBEKura Oncology Announces Senior Executive Promotions
06/1/202522:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:07EDGAR2Form 8-K - Current report
09/12/202413:00GLOBEKura Oncology and Kyowa Kirin Report Positive Combination..
02/12/202413:30GLOBEKura Oncology to Host Virtual Investor Event on December 9,..
25/11/202413:30GLOBEKura Oncology to Participate in JMP Securities Hematology..
20/11/202423:21EDGAR2Form 8-K - Current report
20/11/202423:00GLOBEKura Oncology and Kyowa Kirin Announce Global Strategic..
19/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:03EDGAR2Form 144 - Report of proposed sale of securities
07/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:10EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEKura Oncology Reports Third Quarter 2024 Financial Results
05/11/202415:09GLOBEKura Oncology to Present Updated Data from KOMET-007..
31/10/202412:30GLOBEKura Oncology to Report Third Quarter 2024 Financial Results
24/10/202413:30GLOBEKura Oncology Reports Preclinical Data Supporting..
23/10/202413:30GLOBEKura Oncology to Present New Data Supporting Combination of..
01/10/202400:30GLOBEKura Oncology Announces Publication of Ziftomenib Phase 1..
Apertura: 7,82 Min: 7,565 Max: 7,89
Chiusura: 7,71

La tua Cronologia

NASDAQ
KURA
Kura Oncology
NASDAQ
MARKP
Remark
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci